Serina Therapeutics, Inc.
SER
$2.57
$0.072.80%
AMEX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 1.43% | -43.32% | -21.75% | -425.18% | -223.90% |
| Total Depreciation and Amortization | 12.50% | 5.88% | -57.14% | -71.43% | -71.93% |
| Total Amortization of Deferred Charges | -- | -- | 625.00% | -- | -- |
| Total Other Non-Cash Items | -57.95% | 9,057.89% | 2.81% | 87.78% | 122.47% |
| Change in Net Operating Assets | -277.62% | 11.65% | -531.98% | 26.22% | 114.75% |
| Cash from Operations | -78.24% | -5.69% | -31.47% | -29.98% | 53.18% |
| Capital Expenditure | 39.13% | -- | 100.00% | -333.33% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 39.13% | -- | 100.00% | -333.33% | -- |
| Total Debt Issued | -- | -- | -100.00% | 61,312.50% | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 725.71% | 2,605,600.00% | 9.65% | 1,680.23% | -87.37% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -6.61% | 429.94% | -90.44% | 7,393.02% | 3.78% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -184.67% | 3,508.40% | -1,373.23% | 189.58% | 167.15% |